These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10138705)

  • 1. The risks and rewards of outcomes management systems.
    Navarro R
    Med Interface; 1994 Nov; 7(11):81-2. PubMed ID: 10138705
    [No Abstract]   [Full Text] [Related]  

  • 2. A changing order for pharmacy.
    Vogenberg FR; Pisano DJ
    Hosp Pharm; 1995 Nov; 30(11):1002, 1005-6, 1008. PubMed ID: 10152915
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacy's framework for drug therapy management.
    Penna P
    Manag Care Interface; 2002 Jul; 15(7):33-4. PubMed ID: 12143294
    [No Abstract]   [Full Text] [Related]  

  • 4. Developing a management plan.
    Willcutts D
    Manag Care Q; 2003; 11(1):7-10. PubMed ID: 12790060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A framework for the practice of pharmacy in the 21st century.
    Penna P
    Manag Care Interface; 2002 Feb; 15(2):63-4. PubMed ID: 11875963
    [No Abstract]   [Full Text] [Related]  

  • 6. Buying an outcomes management system.
    Plocher DW; Wilson WL
    Healthc Inform; 2002 Oct; 19(10):71-4. PubMed ID: 12440308
    [No Abstract]   [Full Text] [Related]  

  • 7. Managed care: the role of outcomes management.
    Nash DB
    J Insur Med; 1992; 24(3):176-9. PubMed ID: 10148485
    [No Abstract]   [Full Text] [Related]  

  • 8. Managed care pharmacy: the job gets more intense.
    Belfiglio G
    Healthplan; 2003; 44(3):62-4, 66. PubMed ID: 12808762
    [No Abstract]   [Full Text] [Related]  

  • 9. Dialogue. The rush to measure outcomes: help or hazard? The shift from efficacy to effectiveness research to demonstrate value.
    Sederer LI
    Behav Healthc Tomorrow; 1995; 4(3):40, 43-4. PubMed ID: 10143418
    [No Abstract]   [Full Text] [Related]  

  • 10. The emerging specialty pharmaceutical market segment.
    Giaquinta D
    Manag Care Interface; 2003 Apr; 16(4):35-6. PubMed ID: 12747139
    [No Abstract]   [Full Text] [Related]  

  • 11. The managed care pharmacy perspective.
    Heaton AH
    Am J Manag Care; 2001 Nov; 7(18 Suppl):S567-70. PubMed ID: 11727394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting and preventing adverse drug reactions in managed care.
    Navarro RP
    Med Interface; 1996 May; 9(5):80-1. PubMed ID: 10157689
    [No Abstract]   [Full Text] [Related]  

  • 13. Managed care pharmacy 101: learning from the students.
    Penna P
    Manag Care Interface; 2005 Apr; 18(4):28, 31. PubMed ID: 15889760
    [No Abstract]   [Full Text] [Related]  

  • 14. Managed care organizations: an introduction--Part II of II.
    Vogenberg FR
    Hosp Pharm; 1995 Feb; 30(2):138, 140-2. PubMed ID: 10184282
    [No Abstract]   [Full Text] [Related]  

  • 15. Oncology: practice guidelines and outcomes measurement.
    McGivney WT; Perkel SJ
    Ambul Outreach; 1998; ():17-9. PubMed ID: 10346577
    [No Abstract]   [Full Text] [Related]  

  • 16. Using clinical information to manage managed care.
    Hollers FK
    Caring; 1995 Aug; 14(8):66-8, 70. PubMed ID: 10151222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated outcomes: where CIOs need to be thinking.
    Shaha SH
    Health Manag Technol; 1998 Sep; 19(10):44-6. PubMed ID: 10185153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical management information systems.
    Cagney T; Woods DR
    Behav Healthc Tomorrow; 1994; 3(1):43-5. PubMed ID: 10142497
    [No Abstract]   [Full Text] [Related]  

  • 19. Sorting out contradictions within managed care.
    Navarro RP
    Med Interface; 1996 Sep; 9(9):85-6. PubMed ID: 10161524
    [No Abstract]   [Full Text] [Related]  

  • 20. Changing the marketing message.
    Navarro RP
    Med Interface; 1995 Jun; 8(6):83-5. PubMed ID: 10142946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.